Skip to Main Content

The brightest star in Boston’s rapidly growing biotech scene isn’t a flashy new player, but rather one of its longest standing companies.

While many biotech stocks have struggled this year amid a broader economic downturn, Vertex Pharmaceuticals has risen 65 percent since its most recent low in October 2021. And the 33-year-old firm is now Boston’s most valuable biotech by a mile.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment